All Stories

  1. Health-Related Quality-of-Life Trajectories over Time in Older Men and Women with Advanced Chronic Kidney Disease
  2. Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy
  3. Using datasets to ascertain the generalizability of clinical cohorts: the example of the European QUALity study on the treatment of advanced chronic kidney disease
  4. Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe
  5. Results in the ESPN/ERA-EDTA Registry suggest disparities in access to kidney transplantation but little variation in graft survival of children across Europe
  6. Renal function decline in older men and women with advanced chronic kidney disease—results from the EQUAL study
  7. International prescribing patterns and polypharmacy in older people with advanced chronic kidney disease: results from the European Quality study
  8. An introduction to joint models—applications in nephrology
  9. Where to look for the most frequent biases?
  10. Intention to treat and per protocol analysis in clinical trials
  11. Kidney function and symptom development over time in elderly patients with advanced chronic kidney disease: results of the EQUAL cohort study
  12. Association Between Renal Function and Troponin T Over Time in Stable Chronic Kidney Disease Patients
  13. The impact of symptoms on health-related quality of life in elderly pre-dialysis patients: effect and importance in the EQUAL study
  14. Uraemic symptom burden and clinical condition in women and men of ≥65 years of age with advanced chronic kidney disease: results from the EQUAL study
  15. Prevalence and Risk of Protein-Energy Wasting Assessed by Subjective Global Assessment in Older Adults With Advanced Chronic Kidney Disease: Results From the EQUAL Study
  16. Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease
  17. A propensity-matched comparison of hard outcomes in children on chronic dialysis
  18. The association of donor and recipient age with graft survival in paediatric renal transplant recipients in a European Society for Paediatric Nephrology/European Renal Association–European Dialysis and Transplantation Association Registry study
  19. Survival in children requiring chronic renal replacement therapy
  20. Mortality risk disparities in children receiving chronic renal replacement therapy for the treatment of end-stage renal disease across Europe: an ESPN-ERA/EDTA registry analysis
  21. Infants Requiring Maintenance Dialysis: Outcomes of Hemodialysis and Peritoneal Dialysis
  22. Mortality risk in European children with end-stage renal disease on dialysis
  23. Disparities in treatment rates of paediatric end-stage renal disease across Europe: insights from the ESPN/ERA-EDTA registry
  24. School-based mass distributions of mebendazole to control soil-transmitted helminthiasis in the Munshiganj and Lakshmipur districts of Bangladesh: An evaluation of the treatment monitoring process and knowledge, attitudes, and practices of the population
  25. Demographics of paediatric renal replacement therapy in Europe: a report of the ESPN/ERA–EDTA registry
  26. Treatment coverage survey after a school-based mass distribution of mebendazole: Kampot Province, Cambodia